{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.110.11.1155",
  "meta" : {
    "versionId" : "16",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "NCQA PHEMUR Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-14"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-09-23"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1155"
    }
  ],
  "version" : "20210923",
  "name" : "HiBVaccine4DoseScheduleAdministered",
  "title" : "HiB Vaccine (4 dose schedule) Administered",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-09-23T01:03:11-04:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for a 4-dose haemophilus influenzae type b (Hib) vaccines.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for a 4-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "concept" : [
          {
            "code" : "90644",
            "display" : "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
          },
          {
            "code" : "90648",
            "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
          },
          {
            "code" : "90698",
            "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:ea52a89a-37af-4be7-a9c4-417c890d6171",
    "timestamp" : "2024-06-14T16:48:21-04:00",
    "total" : 3,
    "contains" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2024",
        "code" : "90644",
        "display" : "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2024",
        "code" : "90648",
        "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2024",
        "code" : "90698",
        "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
      }
    ]
  }
}
